Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -7992.04%, near the high end of its 5-year range (-832333.33%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
-13586.47%
NET PROFIT MARGIN AVG 5Y
-7992.04%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Fractyl Health, Inc.
Market Cap
$60.42M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-13586.47%
5Y Avg
-7992.04%
Market Cap
$60.02M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$59.18M
Net Profit Margin
-34.06%
TTM Avg
-499.05%
3Y Avg
-249.52%
5Y Avg
-166.35%
Market Cap
$58.44M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$58.43M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-69.82%
5Y Avg
-186.89%
Market Cap
$58.29M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$62.62M
Net Profit Margin
-621.71%
TTM Avg
-10746.07%
3Y Avg
-5373.04%
5Y Avg
-3582.02%
Market Cap
$58.06M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$62.78M
Net Profit Margin
-22.52%
TTM Avg
-11.22%
3Y Avg
-69.63%
5Y Avg
-131.75%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fractyl Health, Inc. (GUTS) | $60.42M | 0.00% | 0.00% | -13586.47% | -7992.04% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.18M | -34.06% | -499.05% | -249.52% | -166.35% |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | 0.00% | 0.00% | -69.82% | -186.89% |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| RenovoRx, Inc. (RNXT)vs › | $62.62M | -621.71% | -10746.07% | -5373.04% | -3582.02% |
| Kalaris Therapeutics Inc (KLRS)vs › | $58.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | -22.52% | -11.22% | -69.63% | -131.75% |
| InterCure Ltd. (INCR)vs › | $63.02M | -13.72% | -20.80% | -11.88% | -17.10% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -832333.33% |
| 2024-09-30 | -165521.43% |
| 2024-06-30 | -40067.44% |
| 2024-03-31 | -10066.67% |
| 2023-12-31 | -274000.00% |
| 2023-09-30 | -43741.67% |
| 2023-06-30 | -41988.89% |
| 2023-03-31 | -238640.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
